Abbott Australasia Pty Limited, a subsidiary of the global healthcare leader Abbott Laboratories, is headquartered in Australia and operates extensively across the Asia-Pacific region. Founded in 1946, Abbott has established itself as a key player in the healthcare industry, focusing on nutrition, diagnostics, medical devices, and pharmaceuticals. The company is renowned for its innovative products, including the FreeStyle Libre glucose monitoring system and Similac infant formula, which cater to diverse health needs. Abbott's commitment to research and development has positioned it as a market leader, consistently delivering high-quality solutions that enhance patient care and improve health outcomes. With a strong reputation for reliability and innovation, Abbott Australasia continues to make significant contributions to the healthcare landscape in Australia and beyond.
How does Abbott Australasia Pty Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abbott Australasia Pty Limited's score of 45 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abbott Australasia Pty Limited, headquartered in Australia, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Abbott Laboratories, which cascades its climate commitments and performance data down to its subsidiaries. Abbott Laboratories has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Abbott Australasia Pty Limited are not detailed in the available information. As a subsidiary, Abbott Australasia's climate commitments are aligned with those of Abbott Laboratories, which is focused on reducing its overall carbon footprint and enhancing sustainability practices across its operations. The lack of specific emissions data suggests that Abbott Australasia is in the process of developing or implementing its own reporting and reduction strategies in line with its parent company's initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abbott Australasia Pty Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.